BOSTON, Jan. 6, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2023 financial results at 6:00 am ET on Tuesday, February 7, 2023. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on February 7, 2023.

The call can be accessed via teleconference at: Q3 2023 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/m6/p/qyrbnnof https://edge.media-server.com/mmc/p/pt8ugsbv 

A replay of the conference call and webcast will be available for one year beginning on February 7, 2023 at 11:00 am ET using the conference call webcast link provided in this press release.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contact: 
Olga Guyette, Sr. Director, Investor Relations & Treasury
(781) 356-9763
This email address is being protected from spambots. You need JavaScript enabled to view it.

Media Contact:
Josh Gitelson, Director, Global Communications
(781) 356-9776
This email address is being protected from spambots. You need JavaScript enabled to view it.